US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 2.4600
  • -0.1600-6.11%
Close Aug 9 16:00 ET
  • 2.6900
  • +0.2300+9.35%
Post 20:01 ET
3.24MMarket Cap-131P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dermata Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-4.18

+55.67%
Analyst Rating

Buy

Mar 28, 2024

Dermata Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Dermata Therapeutics Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 7 16:12 ET

  • 10-Q: Q1 2024 Earnings Report

    May 15 22:23 ET

  • Dermata Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 16:10 ET

  • Dermata Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 28, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg